Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Ebbesen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 11, 2005
Hyperhomocysteinemia, thrombosis and vascular biologyL S Ebbesen
The Canadian Nurse|February 1, 1997
Heart health in rural SaskatchewanL S Ebbesen, V R Ramsden, B A Reeder, et al.
Journal of Clinical Epidemiology|January 1, 1990
Measuring quality of life in cardiac spousesL S Ebbesen, G H Guyatt, N McCartney, et al.
Heart & Lung : the Journal of Critical Care|March 1, 1996
Anxiety and depression after acute myocardial infarctionJ M Crowe, J Runions, L S Ebbesen, et al.
International Journal of Colorectal Disease|July 19, 2001
Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized studyI L Titlestad, L S Ebbesen, A P Ainsworth, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitorsB A Konkle, L S Ebbesen, E Erhardtsen, et al.
Promotion & Education|October 27, 2001
The Saskatchewan dissemination storyL S Ebbesen, G B Woodard, S McLean, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 20, 2008
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitorsW K Hoots, L S Ebbesen, B A Konkle, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 11, 2005
Hyperhomocysteinemia, thrombosis and vascular biologyL S Ebbesen
The Canadian Nurse|February 1, 1997
Heart health in rural SaskatchewanL S Ebbesen, V R Ramsden, B A Reeder, et al.
Journal of Clinical Epidemiology|January 1, 1990
Measuring quality of life in cardiac spousesL S Ebbesen, G H Guyatt, N McCartney, et al.
Heart & Lung : the Journal of Critical Care|March 1, 1996
Anxiety and depression after acute myocardial infarctionJ M Crowe, J Runions, L S Ebbesen, et al.
International Journal of Colorectal Disease|July 19, 2001
Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized studyI L Titlestad, L S Ebbesen, A P Ainsworth, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitorsB A Konkle, L S Ebbesen, E Erhardtsen, et al.
Promotion & Education|October 27, 2001
The Saskatchewan dissemination storyL S Ebbesen, G B Woodard, S McLean, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 20, 2008
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitorsW K Hoots, L S Ebbesen, B A Konkle, et al.
Pageof 1